Literature DB >> 23241590

Activation profiles of human kallikrein-related peptidases by matrix metalloproteinases.

Hyesook Yoon1, Sachiko I Blaber, Wu Li, Isobel A Scarisbrick, Michael Blaber.   

Abstract

The 15 human kallikrein-related peptidases (KLKs) are clinically important biomarkers and therapeutic targets of interest in inflammation, cancer, and neurodegenerative disease. KLKs are secreted as inactive pro-forms (pro-KLKs) that are activated extracellularly by specific proteolytic release of their amino-terminal pro-peptide, and this is a key step in their functional regulation. Physiologically relevant KLK regulatory cascades of activation have been described in skin desquamation and semen liquefaction, and work by a large number of investigators has elucidated pairwise and autolytic activation relationships among the KLKs with the potential for more extensive activation cascades. More recent work has asked whether functional intersection of KLKs with other types of regulatory proteases exists. Such studies show a capacity for members of the thrombostasis axis to act as broad activators of pro-KLKs. In the present report, we ask whether such functional intersection is possible between the KLKs and the members of the matrix metalloproteinase (MMP) family by evaluating the ability of the MMPs to activate pro-KLKs. The results identify MMP-20 as a broad activator of pro-KLKs, suggesting the potential for intersection of the KLK and MMP axes under pathological dysregulation of MMP-20 expression.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23241590      PMCID: PMC3709557          DOI: 10.1515/hsz-2012-0249

Source DB:  PubMed          Journal:  Biol Chem        ISSN: 1431-6730            Impact factor:   3.915


  47 in total

Review 1.  Matrix metalloproteinases and the regulation of tissue remodelling.

Authors:  Andrea Page-McCaw; Andrew J Ewald; Zena Werb
Journal:  Nat Rev Mol Cell Biol       Date:  2007-03       Impact factor: 94.444

2.  Distribution of 15 human kallikreins in tissues and biological fluids.

Authors:  Julie L V Shaw; Eleftherios P Diamandis
Journal:  Clin Chem       Date:  2007-06-15       Impact factor: 8.327

3.  Molecular cloning and mRNA tissue distribution of a novel matrix metalloproteinase isolated from porcine enamel organ.

Authors:  J D Bartlett; J P Simmer; J Xue; H C Margolis; E C Moreno
Journal:  Gene       Date:  1996-12-12       Impact factor: 3.688

4.  Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate.

Authors:  T A Stamey; N Yang; A R Hay; J E McNeal; F S Freiha; E Redwine
Journal:  N Engl J Med       Date:  1987-10-08       Impact factor: 91.245

5.  Characterization of recombinant pig enamelysin activity and cleavage of recombinant pig and mouse amelogenins.

Authors:  O H Ryu; A G Fincham; C C Hu; C Zhang; Q Qian; J D Bartlett; J P Simmer
Journal:  J Dent Res       Date:  1999-03       Impact factor: 6.116

6.  Potential scope of action of tissue kallikreins in CNS immune-mediated disease.

Authors:  I A Scarisbrick; S I Blaber; J T Tingling; M Rodriguez; M Blaber; G P Christophi
Journal:  J Neuroimmunol       Date:  2006-07-07       Impact factor: 3.478

7.  Crystal structure and biochemical characterization of human kallikrein 6 reveals that a trypsin-like kallikrein is expressed in the central nervous system.

Authors:  Matthew J Bernett; Sachiko I Blaber; Isobel A Scarisbrick; Pushparani Dhanarajan; Steven M Thompson; Michael Blaber
Journal:  J Biol Chem       Date:  2002-04-30       Impact factor: 5.157

Review 8.  Kallikreins, kinins and cardiovascular diseases: a short review.

Authors:  H S Margolius
Journal:  Biol Res       Date:  1998       Impact factor: 5.612

9.  MMP-20 is predominately a tooth-specific enzyme with a deep catalytic pocket that hydrolyzes type V collagen.

Authors:  Benjamin E Turk; Daniel H Lee; Yasuo Yamakoshi; Andreas Klingenhoff; Ernst Reichenberger; J Timothy Wright; James P Simmer; Justin A Komisarof; Lewis C Cantley; John D Bartlett
Journal:  Biochemistry       Date:  2006-03-28       Impact factor: 3.162

Review 10.  Tissue kallikrein proteolytic cascade pathways in normal physiology and cancer.

Authors:  Georgios Pampalakis; Georgia Sotiropoulou
Journal:  Biochim Biophys Acta       Date:  2007-06-14
View more
  19 in total

1.  Proteomic profiling of the dystrophin complex and membrane fraction from dystrophic mdx muscle reveals decreases in the cytolinker desmoglein and increases in the extracellular matrix stabilizers biglycan and fibronectin.

Authors:  Sandra Murphy; Heinrich Brinkmeier; Mirjam Krautwald; Michael Henry; Paula Meleady; Kay Ohlendieck
Journal:  J Muscle Res Cell Motil       Date:  2017-08-12       Impact factor: 2.698

2.  MMP20 and KLK4 activation and inactivation interactions in vitro.

Authors:  Yasuo Yamakoshi; James P Simmer; John D Bartlett; Takeo Karakida; Shinichiro Oida
Journal:  Arch Oral Biol       Date:  2013-08-18       Impact factor: 2.633

Review 3.  Putative functions of tissue kallikrein-related peptidases in vaginal fluid.

Authors:  Carla M J Muytjens; Stella K Vasiliou; Katerina Oikonomopoulou; Ioannis Prassas; Eleftherios P Diamandis
Journal:  Nat Rev Urol       Date:  2016-09-07       Impact factor: 14.432

4.  Matrix metalloproteinase processing of PTHrP yields a selective regulator of osteogenesis, PTHrP1-17.

Authors:  J S Frieling; G Shay; V Izumi; S T Aherne; R G Saul; M Budzevich; J Koomen; C C Lynch
Journal:  Oncogene       Date:  2017-04-03       Impact factor: 9.867

5.  Pericellular regulation of prostate cancer expressed kallikrein-related peptidases and matrix metalloproteinases by cell surface serine proteases.

Authors:  Janet C Reid; Admire Matsika; Claire M Davies; Yaowu He; Amy Broomfield; Nigel C Bennett; Viktor Magdolen; Bhuvana Srinivasan; Judith A Clements; John D Hooper
Journal:  Am J Cancer Res       Date:  2017-11-01       Impact factor: 6.166

6.  MMP8 increases tongue carcinoma cell-cell adhesion and diminishes migration via cleavage of anti-adhesive FXYD5.

Authors:  K Juurikka; A Dufour; K Pehkonen; B Mainoli; P Campioni Rodrigues; N Solis; T Klein; P Nyberg; C M Overall; T Salo; P Åström
Journal:  Oncogenesis       Date:  2021-05-31       Impact factor: 7.485

Review 7.  Remodelling of the tumour microenvironment by the kallikrein-related peptidases.

Authors:  Srilakshmi Srinivasan; Thomas Kryza; Jyotsna Batra; Judith Clements
Journal:  Nat Rev Cancer       Date:  2022-01-31       Impact factor: 69.800

Review 8.  Involvement of Kallikrein-Related Peptidases in Normal and Pathologic Processes.

Authors:  Ana Carolina B Stefanini; Bianca Rodrigues da Cunha; Tiago Henrique; Eloiza H Tajara
Journal:  Dis Markers       Date:  2015-12-09       Impact factor: 3.434

9.  Kallikrein-related peptidase 5 induces miRNA-mediated anti-oncogenic pathways in breast cancer.

Authors:  Konstantinos G Sidiropoulos; Nicole M A White; Anna Bui; Qiang Ding; Peter Boulos; Georgios Pampalakis; Heba Khella; Joseph N Samuel; Georgia Sotiropoulou; George M Yousef
Journal:  Oncoscience       Date:  2014-10-24

Review 10.  Metastasis of ovarian cancer is mediated by kallikrein related peptidases.

Authors:  Ying Dong; Daniela Loessner; Helen Irving-Rodgers; Andreas Obermair; James L Nicklin; Judith A Clements
Journal:  Clin Exp Metastasis       Date:  2013-09-17       Impact factor: 5.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.